Stem Pharm

About:

Stem Pharm's synthetic biomaterials support the optimization of cell expansion.

Website: https://stempharm.com

Twitter/X: stempharm

Top Investors: National Institutes of Health, Small Business Innovation Research, Wisconsin Economic Development, SBIR Advance

Description:

Stem Pharm was founded in 2015 with the purpose of being a trusted supplier of synthetic biomaterials that are specifically designed to meet customer's requirements as they develop more advanced cellular models for drug discovery and toxicity screening and cellular therapies for regenerative medicine applications. Stem Pharm is located in the Fitchburg Technology Campus, near the University of Wisconsin campus. It Leverages its expertise in biomaterials and cellular interactions to develop high-value applications of organoids (3-D in vitro models) for drug discovery and cell-friendly coatings for the manufacture of-cell based therapies.